Logo
SYK

SYK

Stryker Corporation

Stryker is a medical technology powerhouse specializing in orthopedic, surgical, and neurotechnology solutions, renowned for its industry-leading Mako robotic surgery systems.

XTRM
RSI
Daily XTRM
63.72
Deep Overbought
Weekly XTRM
0.00
Neutral
Current Price
$364.56
Latest Close

Historical oversold levels

Track when SYK has reached extreme oversold conditions (XTRM below -125) historically. These levels represent prolonged periods in extreme territory and often present potential opportunities.

SYK has no extreme XTRM events on the daily timeframe.

SYK has no extreme XTRM events on the weekly timeframe.

Get Oversold Alerts
avataravataravatar
1,500+ subscribers

What is SYK?

Stryker was founded in 1941 by Dr. Homer Stryker, an orthopedic surgeon who started out by inventing the mobile hospital bed and the turning frame to prevent pressure sores. Since those early days in Kalamazoo, Michigan, the company has grown into a global medical technology giant. Its business model is incredibly resilient because it is diversified across several high-margin healthcare sectors. They do not just sell products; they sell integrated surgical ecosystems that help hospitals reduce costs and improve patient outcomes through better efficiency and precision.

The product lineup is divided into MedSurg, Neurotechnology, and Orthopaedics. While they are a household name for joint replacements, their Mako robotic-arm assisted surgery platform is the real crown jewel. It allows surgeons to perform knee and hip replacements with insane accuracy. Other key milestones include the 2013 acquisition of MAKO Surgical and the 2020 purchase of Wright Medical, which solidified their lead in the extremities and biologics markets. Beyond the heavy hardware, they produce everything from endoscopic cameras to neurovascular coils used to treat strokes.

From a financial perspective, Stryker is a consistent outperformer. They have maintained a strong track record of organic sales growth and have been aggressive with their dividend increases. Their balance sheet is healthy, allowing them to reinvest heavily in research and development while maintaining a steady pace of strategic acquisitions. They have shown a remarkable ability to pass on costs and manage supply chain issues better than many of their peers in the med-tech space.

Looking ahead to 2026, Stryker strategic outlook is centered on the digitalization of the operating room. They are moving toward a more data-centric model where the Mako system uses artificial intelligence to optimize surgical workflows in real-time. We will likely see a significant expansion into ambulatory surgery centers as more procedures shift away from large hospitals. By 2026, their focus on smart implants and connected hospital infrastructure should drive even higher margins and solidify their status as the go-to partner for healthcare providers worldwide.

What is the XTRM Indicator?

The XTRM (Extreme) Indicator is a proprietary momentum indicator that measures cumulative time spent in extreme territory. Unlike traditional oscillators like RSI that measure a snapshot in time, XTRM accumulates how long an asset remains in oversold or overbought conditions, providing a deeper understanding of momentum exhaustion.

For SYK, monitoring the XTRM indicator provides valuable insights into prolonged extreme conditions. When the XTRM drops significantly below zero (especially below -125), Stryker Corporation has been in oversold territory for an extended period, suggesting potential for a reversal. Conversely, high positive XTRM values indicate extended overbought conditions.

Understanding SYK XTRM Signals

  • Deep Oversold (XTRM below -125): When SYK XTRM falls below -125, it indicates prolonged time in extreme oversold conditions. This cumulative measure often provides stronger reversal signals than single-day oversold readings.
  • Neutral Zone (XTRM near 0): When XTRM hovers around zero, SYK is in a balanced state without extended extreme conditions. This can indicate consolidation or indecision in the market.
  • Overbought (XTRM above +10): An XTRM above +10 indicates SYK has been in overbought territory for an extended period, potentially signaling an overextended rally and increased risk of pullback.

Daily vs Weekly XTRM for SYK

This page displays both daily and weekly XTRM for SYK. The daily XTRM tracks short-term cumulative extremes, useful for identifying swing trading opportunities. The weekly XTRM provides a longer-term perspective on momentum exhaustion, helping investors spot major turning points.

By analyzing both timeframes together, you can identify when Stryker Corporation is experiencing extreme conditions at multiple time scales, which often leads to the strongest reversal setups.

Historical XTRM Extreme Analysis

Above, we track historical instances when SYK XTRM dropped below -125 (extreme oversold territory). These periods represent times when Stryker Corporation spent extended periods in oversold conditions, which historically have presented some of the best buying opportunities. Analyzing how SYK behaved after reaching these extreme XTRM levels can help inform future trading decisions.

Logo